康健醫療(03886.HK)急漲20% 料全年虧轉盈
康健國際醫療(03886.HK)發盈喜料全年扭虧爲盈,該股逆市一舉升破10天、20天及50天線(0.38-0.408元),最高見0.46元,創逾兩個月高,現報0.445元,急漲20%,一向薄弱成交急增至962萬股。
康健國際醫療上週五(11日)收市後發盈喜預計,截至去年底止全年業績扭虧轉賺5,000萬至8,000萬元(上年蝕約2.58億元),主要由於醫療服務、內地醫院管理和相關服務,以及新冠病毒檢測服務需求增加,推動年度收入按年增加;另期內錄得投資物業公平值收益和應佔聯營公司溢利按年增加;以及相關資產錄得預期信貸虧損及減值虧損減少。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.